methyleugenol has been researched along with amphotericin b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enriz, RD; Furlán, RL; Giannini, FA; López, SN; Muñoz, L; Pezzenati, GD; Rodríguez, AM; Santecchia, CB; Zacchino, SA | 1 |
| Charan Raja, MR; Chellappan, D; Debnath, J; Kar Mahapatra, S; Velappan, AB | 1 |
2 other study(ies) available for methyleugenol and amphotericin b
| Article | Year |
|---|---|
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Drug Evaluation; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Phenylpropionates; Structure-Activity Relationship | 1999 |
Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Eugenol; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; RAW 264.7 Cells; Structure-Activity Relationship | 2017 |